LTB4DH Antilichaam - N-terminalgebied: Biotine (ARP54865 P050-Biotine)

Prostaglandin reductase 1

PGR1, DIG-1, ZADH3, LTB4DH

22949

A8K0N2

NP_036344

Human, Rat, Cow, Guinea Pig, Horse, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human LTB4DH

LTB4DH functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. It has no activity towards PGE1, PGE2 and PGE2-alpha. LTB4DH catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4.

PRDX5; PEBP1; ATP6V1A; UBC

Biotin

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Cow: 93%; Guinea Pig: 83%; Horse: 83%; Human: 93%; Rabbit: 83%; Rat: 79%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

36kDa

Chou, W.L., (2007) J. Biol. Chem. 282 (25), 18162-18172

Wet Ice

329

PTGR1

PTGR1

Rabbit

Prostaglandin reductase 1

NM_012212

VRTKTWTLKKHFVGYPTNSDFELKTSELPPLKNGEVLLEALFLTVDPYMR